Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9K Sell
382
-138
-27% -$2.97K 0.01% 1483
2025
Q4
$10K Buy
520
+24
+5% +$469 0.01% 1580
2025
Q3
$9K Sell
496
-58
-10% -$1.13K 0.01% 1666
2025
Q2
$11K Sell
554
-106
-16% -$2.04K 0.01% 1532
2025
Q1
$12K Buy
660
+23
+4% +$412 0.01% 1396
2024
Q4
$11K Sell
637
-40
-6% -$768 0.01% 1483
2024
Q3
$13K Sell
677
-174
-20% -$3.21K 0.01% 1395
2024
Q2
$14K Buy
851
+38
+5% +$590 0.01% 1339
2024
Q1
$12K Buy
813
+29
+4% +$456 0.01% 1451
2023
Q4
$12K Buy
784
+751
+2,276% +$10.5K 0.01% 1427
2023
Q3
$0 Sell
33
-32
-49% -$416 ﹤0.01% 2380
2023
Q2
$1K Sell
65
-414
-86% -$5.18K ﹤0.01% 1964
2023
Q1
$5K Buy
479
+114
+31% +$1.38K ﹤0.01% 1562
2022
Q4
$5K Sell
365
-23
-6% -$302 ﹤0.01% 1572
2022
Q3
$5K Buy
388
+94
+32% +$1.29K ﹤0.01% 1492
2022
Q2
$4K Sell
294
-164
-36% -$2.69K ﹤0.01% 1470
2022
Q1
$9K Buy
458
+118
+35% +$2.11K 0.01% 1347
2021
Q4
$6K Buy
+340
New +$5.79K 0.01% 1227

Other funds holding INVA

Covestor's INVA Position: Q1 2026 in Review

Covestor reduced its Innoviva (INVA) stake by 27% in Q1 2026, selling an estimated $2.97K and leaving 382 shares worth $9K. The position accounts for 0.01% of the portfolio, ranked #1483.

Covestor first reported a position in INVA in Q4 2021 and has held it in 18 quarters since. The position peaked at $14K in Q2 2024. 286 funds tracked by Wall St. Rank hold INVA as of Q1 2026.

  • Covestor held 382 shares of Innoviva worth $9K as of Q1 2026.
  • Covestor sold 138 Innoviva shares in Q1 2026, an estimated $2.97K.
  • Innoviva made up 0.01% of Covestor's portfolio in Q1 2026, its #1483 holding.
  • Covestor first reported a position in Innoviva in Q4 2021 and has held it in 18 quarters since.
  • Covestor's Innoviva position peaked at $14K in Q2 2024.
  • 286 funds tracked by Wall St. Rank held Innoviva as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.